VF
Virtu Financial’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $865K | Buy |
51,601
+27,447
| +114% | +$460K | 0.04% | 387 |
|
|
2025
Q1 | $371K | Buy |
+24,154
| New | +$371K | 0.02% | 592 |
|
|
2023
Q2 | – | Sell |
-59,842
| Closed | -$530K | – | 2033 |
|
|
2023
Q1 | $530K | Buy |
+59,842
| New | +$530K | 0.06% | 327 |
|
|
2022
Q4 | – | Sell |
-117,906
| Closed | -$951K | – | 2123 |
|
|
2022
Q3 | $951K | Sell |
117,906
-193,682
| -62% | -$1.56M | 0.09% | 209 |
|
|
2022
Q2 | $2.34M | Buy |
+311,588
| New | +$2.34M | 0.2% | 83 |
|
|
2022
Q1 | – | Sell |
-160,971
| Closed | -$1.29M | – | 2020 |
|
|
2021
Q4 | $1.29M | Buy |
+160,971
| New | +$1.29M | 0.13% | 149 |
|
|
2020
Q4 | – | Sell |
-18,242
| Closed | -$164K | – | 1787 |
|
|
2020
Q3 | $164K | Sell |
18,242
-5,834
| -24% | -$52.4K | 0.03% | 629 |
|
|
2020
Q2 | $297K | Buy |
+24,076
| New | +$297K | 0.03% | 557 |
|
|
2019
Q4 | $3.72M | Buy |
380,072
+170,752
| +82% | +$1.67M | 0.36% | 44 |
|
|
2019
Q3 | $1.44M | Buy |
209,320
+156,871
| +299% | +$1.08M | 0.11% | 188 |
|
|
2019
Q2 | $484K | Sell |
52,449
-23,231
| -31% | -$214K | 0.03% | 529 |
|
|
2019
Q1 | $1.19M | Sell |
75,680
-19,763
| -21% | -$310K | 0.07% | 259 |
|
|
2018
Q4 | $1.47M | Sell |
95,443
-176,094
| -65% | -$2.72M | 0.08% | 182 |
|
|
2018
Q3 | $5.85M | Buy |
271,537
+236,044
| +665% | +$5.08M | 0.36% | 34 |
|
|
2018
Q2 | $863K | Buy |
35,493
+10,948
| +45% | +$266K | 0.05% | 477 |
|
|
2018
Q1 | $419K | Buy |
+24,545
| New | +$419K | 0.02% | 808 |
|
|
2017
Q4 | – | Sell |
-66,168
| Closed | -$1.17M | – | 2993 |
|
|
2017
Q3 | $1.17M | Buy |
+66,168
| New | +$1.17M | 0.06% | 380 |
|
|
2017
Q2 | – | Sell |
-6,225
| Closed | -$200K | – | 512 |
|
|
2017
Q1 | $200K | Buy |
+6,225
| New | +$200K | 0.02% | 363 |
|